• Foot Care Kickin’ with 5.7% Sales Growth
• Oh My Aching Feet!
• Figure 2-1 U.S. Retail Sales of Foot Care Products, 2002-2006 (in million $)
• Table 2-1 Foot Ailment Breakdown, 2006 (%)

• Devices and Medications Grow on Parallel Paths in 2006
• Figure 2-3 U.S. Retail Sales Trends by Foot Care Category, 2002-2006 (in million $)
• Figure 2-4 Market Share of Foot Care Products by Category, 2002-2006 (%)
• Strong Private Label Competition
• Figure 2-5 U.S. Retail Sales Trends, Branded vs. Private Label Foot Care Devices, 2002-2006 (in million $)
• Figure 2-6 U.S. Retail Sales Trends, Branded vs. Private Label Foot Care Medication, 2002-2006 (in million $)
• Figure 2-7 Market Share of Branded U.S. Retail Sales by Foot Care Category, 2002-2006

• Foot Care to Surpass $900 Million by 2011
• Figure 2-8 Projected U.S. Retail Foot Care Market Sales, 2006-2011
• (in million $)

Chapter 3 Growth Factors

• Private Label Booming
• Figure 3-1 U.S. Foot Care Retail Sales Growth, Branded vs. Private Label, 2002-2006 (in million $)
• Figure 3-2 Share of U.S. Foot Care Retail Sales, Branded vs. Private Label, 2002-2006
• Keeping It Fresh
• More Face Time with Private Label
• The Value of the Boomer
• No Time for Aches and Pains
• Table 3-1 Projected U.S. Population, by Age Bracket, 2000-2020 (in thousands)
• Diabetes a National Problem… and Market Opportunity Figure 3-3 Percentage of Adults with Diabetes, 2005
• Figure 3-4 Number of New Diabetes Cases Diagnosed in 2005 (in thousands)
• Creating a Spa Experience
• The Health and Beauty Invasion
• Broadening Foot Care Appeal to Women
• Sof Sole Energy—First Line of Foot Care Accessories Created Just for Women
• Increasing Accessibility: Expanding Beyond Mass and Drug
• Podiatry Services
• Department Stores
• Independent Retailers

Chapter 4 Foot Care Brands and their Marketers

• Overall Market Performance
• Table 4-1 IRI-Tracked Dollar Sales of Total Foot Care Products, 2002-2006 (in million $)
• Figure 4-1 IRI-Tracked Dollar Sales of Total Foot Care Products, 2002-2006 (in million $)
• Medication Growing Faster Than Devices
• Figure 4-2 Foot Care Sales by Category, 2002-2006 (in million $)
• Schering-Plough the Clear Leader
• Figure 4-3 Foot Care Sales by Marketer, 2006 (%)
• Implus and Del Labs’ Breakout Performance
• Figure 4-4 Foot Care Sales, Top 10 Marketers, 2004-2006 (in million $)
• Table 4-3 Foot Care Sales, Top 10 Marketers, 2002-2006 (in million $)
• By Brand, Dr Scholl’s Hot
• Figure 4-5 Top 10 Foot Care Brands by Sales, 2004-2006 (in million $)
• Table 4-4 Top 10 Foot Care Brands by Sales, 2002-2006 (in million $)

• Schering-Plough Dominates Devices
• Figure 4-6 Percentage of Foot Care Device Sales by Top Marketers, 2006
• Limited Star Performances in Devices
• Figure 4-7 Foot Care Device Sales, Top 10 Marketers, 2004-2006 (in million $)
• Table 4-5 Foot Care Device Sales, Top Ten Marketers, 2002-2006 (in million $)
• Table 4-6 Foot Care Device Sales Change, Top 10 Marketers, 2005 and 2006 (in million $ and %)
• Dr Scholl’s Hard to Ignore
• Figure 4-8 Top 10 Foot Care Device Brands by Sales, 2004-2006 (in million $)
• Table 4-7 Top 10 Foot Care Device Brands by Sales, 2002-2006 (in million $)

• Schering-Plough Continues to Dominate Medication
• Del Labs a Stand Out in Medication
• Figure 4-9 Percentage of Foot Care Medication Sales by Top Marketers,
• 2006 (%)
• Figure 4-10 Foot Care Medication Sales, Top 10 Marketers, 2006 (in million $)
• Table 4-8 Foot Care Medication Sales, Top 10 Marketers, 2002-2006 (in million $)
• Competition Among the Top Foot Care Medication Brands
• Figure 4-11 Top Foot Care Medication Brands by Sales, 2004-2006 (in million $)
• Table 4-9 Top 10 Medication Brands by Sales, 2002-2006 (in million $)

Chapter 5 Corporate Profiles

• Schering-Plough
• Overview
• Performance
• Figure 5-1 Schering-Plough Performance, Foot Care Products, 2002-2006 (in million $)
• Figure 5-2 Schering-Plough Foot Care Brand Sales, 2002-2006 (in million $)
• Recent Activity
• Novartis
  • Overview
  • Performance
  • Figure 5-3 Novartis Performance, Foot Care Medication, 2002-2006
  • (in million $)
  • Recent Activity
  
  
• Combe
  • Overview
  • Performance
  • Figure 5-4 Combe Performance, Foot Care Products, 2002-2006 (in million $)
  • Recent Activity
  
  
• ProFoot, Inc.
  • Overview
  • Performance
  • Figure 5-5 ProFoot Performance, Foot Care Products, 2002-2006 (in million $)
  • Recent Activity
  
  
• Implus Footcare
  • Overview
  • Performance
  • Figure 5-6 Implus Performance, Foot Care Products,* 2002-2006 (in million $)
  • Recent Activity
  
  
• Chattem
  • Overview
  • Performance
  • Figure 5-7 Chattem Performance, Gold Bond, 2002-2006 (in million $)
  • Recent Activity
  • Overview
  • Performance
  • Figure 5-8 Del Labs Performance, Foot Care Products, 2002-2006 (in million $)
  • Recent Activity
  
  
• Alva-Amco
  • Overview
  • Performance
  • Figure 5-9 Alva-Amco Performance, Foot Care Products,* 2002-2006 (in million $)
  • Recent Activity
  
  
• Pedifix
  • Overview
  • Figure 5-10 Pedifix Performance, Foot Care Products, 2002-2006 (in million $)
  • Performance
  • Recent Activity

Chapter 6 Marketing Dynamics

• Foot Care Industry Light on Marketing
• 2005 Foot Care Ad Spend Data
• Table 6-1 Advertising Spend for Foot Care Brands, 2005
• Lamisil by Novartis Top Spender
• TV Dominates
• Sporting Sponsorships
• In-Store
• Opportunity Marketing
• Packaging
• An Upscale Climb
• Figure 6-1 New Lamisil Packaging
• Figure 6-2 Implus Foot Care Products For Active Individuals
• Stepping Up Women’s Products
• Figure 6-3 Sally Hansen Packaging Line
• Figure 6-4 Implus Foot Care Packaging Line for Women
• Figure 6-5 Dr Scholl’s for Her
• Value Promise at Odds With Spa Promise
• Figure 6-6 Pedifix Packaging
• Functional Benefits Still Reign
• New Entrants
• Novartis and Del Labs Stand Out with New Medications
• Figure 6-7 New Product Packaging
• Athletic Products Cross Over
• Table 6-2 New Products from Top 10 Foot Care Medication Companies, 2006
• Private Label Stands Out with New Devices
• Pedifix and Implus Vying for the Upper-End Device Market
• Table 6-3 New Products from Top 10 Device Manufacturers, 2006

Chapter 7 The Consumer

• Simmons Market Research Bureau Survey
• Toughing It Out
• Pain and Suffering
• Table 7-1 Foot Ailment Breakdown, 2006 (%)
• Table 7-2 Percentage of Consumers Reporting Foot Ailments Suffered over Past 12 Months, 2006 (%)
• To See or Not to See the Doctor. That is the Question
• Table 7-3 Percentage of Consumers Who Suffered Foot Care Ailments in the Last 12 Months, 2003-2006
• Table 7-4 Percentage of Consumers Who Treated a Foot Ailment in the Last 12 Months, 2003-2006
• Form Factor: Lube Me Up
• Table 7-5: Household Penetration Rates for First Aid/Antibiotic Remedies, by Form, 2003-2006 (%)
• Whose Feet are the Scariest?
• Most Report Mild to Moderate Severity
• Table 7-6 Consumers’ Level of Foot Ailment Severity, 2006 (%)
• Table 7-7 Percentage of Consumers Who Feel at Risk for Foot Ailments, 2003-2006
• Older Consumers More likely to Seek Treatment
• Table 7-8 Index of Foot Ailments and Treatment Usage by Age, 2006 (%)
• Table 7-9 Willingness to Consult a Podiatrist, by Age and Gender, 2006 (%)
• West Coast a Breeding Ground for Foot Ailments?
• Education and Job Status a Factor
• Table 7-10 Key Demographic Indicators: Regional, Education, Employment and Income, 2006
• Table 7-10 [Cont.] Key Demographic Indicators: Regional, Education, Employment and Income, 2006
• Profile of an Athlete’s Foot Sufferer
• Profile of a Nail Fungus Sufferer